AACR-NCI-EORTC--17th Symposium: Molecular Targets and Cancer Therapeutics
Garvey, R.
IDrugs the investigational drugs journal 9(2): 90-92
2006
ISSN/ISBN: 1369-7056 PMID: 16523394 Document Number: 596551
Document emailed within 1 workday
Related Documents
Collins, T. 2007: AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3 IDrugs: the investigational drugs journal 10(12): 840-843Veryard, C. 2006: AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. 14-18th November 2005, Philadelphia, PA, USA IDrugs: the investigational drugs journal 9(1): 1-3
Lunec, A. 2004: EORTC-NCI-AACR--16th Symposium. Kinase inhibitors. 28 September-1 October 2004, Geneva, Switzerland IDrugs: the investigational drugs journal 7(11): 965-967
Kelland, L. 1998: NCI-EORTC--10th Symposium--new approaches and cellular targets. 16-19 June 1998, Amsterdam, The Netherlands IDrugs: the investigational drugs journal 1(4): 391-393
Scholl, S.M. 2001: Molecular targets and cancer therapeutics: discovery, biology and clinical applications Idrugs: the Investigational Drugs Journal 4(12): 1357-1360
Brissette, R.; Prendergast, J.K.A.; Goldstein, N.I. 2006: Identification of cancer targets and therapeutics using phage display Current Opinion in Drug Discovery and Development 9(3): 363-369
El-Deiry, W. 2000: AACR - 91st meeting. Novel concepts and targets for therapeutic manipulation IDrugs: the investigational drugs journal 3(7): 717-718
Herber, D.L. 2007: Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer IDrugs: the investigational drugs journal 10(4): 227-229
Mitsudomi, T. 2002: Molecular lesions as targets for diagnosis and therapy of lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 112-116
Ashok, B.T.; Chen, Y.G.; Liu, X.; Garikapaty, V.P.S.; Seplowitz, R.; Tschorn, J.; Roy, K.; Mittelman, A.; Tiwari, R.K. 2002: Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 11 Suppl. 2: S86-S93
Jakse, G. 1989: Intravesical instillation of BCG in carcinoma in situ of the urinary bladder. EORTC protocol 30861. EORTC-GU Group Progress in Clinical and Biological Research 310: 187-192
McKinnon, C. 1998: American Society of Clinical Oncology--34th Annual Meeting. Treatments for prostate cancer and new molecular targets. 16-19 May 1998, Los Angeles, California, USA IDrugs: the investigational drugs journal 1(2): 163-167
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Saklatvala, J.; Nagase, H. 2004: Report on the Molecular Approaches to Osteoarthritis Symposium, Imperial College London, UK, 18-20 April 2004 Arthritis Research and Therapy 6(5): 203-207
Robinson, M.R.; Smith, P.H.; Macaluso, M.P.; Sylvester, R.; de Voogt, H. 1985: The EORTC Phase IIi trials in prostatic cancer Progress in Clinical and Biological Research 185a: 243-249
Pavone-Macaluso, M.; Lund, F.; Mulder, J.H.; Smith, P.H.; De Pauw, M.; Sylvester, R. 1980: EORTC protocols in prostatic cancer. An interim report Scandinavian Journal of Urology and Nephrology. Supplementum 55: 163-168
Atkinson, E.M.; Christensen, J.R. 1999: Process and product development in the manufacturing of molecular therapeutics Idrugs: the Investigational Drugs Journal 2(10): 1031-1038
Gorman, J.M. 2003: New molecular targets for antianxiety interventions Journal of Clinical Psychiatry 64(Suppl 3): 28-35
Coleman, R. 2018: Setting the scene, setting the targets. The Joint United Nations Programme on HIV/AIDS prevention targets of 2016 and estimating global pre-exposure prophylaxis targets Sexual Health 15(6): 485-488
Bogush, T.A.; Dudko, E.A.; Bogush, E.A.; Polotskiĭ, B.E.; Tiuliandin, S.A.; Davydov, M.I. 2012: Tamoxifen molecular targets different from estrogen receptors Antibiotiki i Khimioterapiia 57(1-2): 50-58